Key players in Lentiviral Vectors
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Oxford Biomedica | — | 66 reports |
| 2 | Lonza Ltd | — | 264 reports |
| 3 | Thermo Fisher Scientific Inc. | — | 1,023 reports |
| 4 | Takara Bio | — | 33 reports |
| 5 |  Charles River Laboratories |
criver.com (opens in a new tab) | 264 reports |
Also active in Lentiviral Vectors
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Orchard Therapeutics |
|
| Rocket Health |
|
| Shanghai BDgene Co., Ltd. |
|
| Genetix Biotherapeutics Inc. |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Lentiviral Vectors
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Orchard Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Rocket Health 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Shanghai BDgene Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Genetix Biotherapeutics Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Lentiviral Vectors reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Lentiviral Vectors report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.